lecture 3: autonomic pharmacology Flashcards
Parasympathetic NS innervation
cranial, sacral nerves
sympathetic NS innervation
thoracic, lumbar
what is an action of the parasympathetic nervous system
salivation increased
sympathetic NS NT
NE, Ep
sympathetic receptros
alpha and beta adrenergic receptors
sympathetic action
fight or flight actions
parasympethic actions
rest and digest actions
parasymathetic NT
ACh
parasympathetic receptor
mACh, nACh
what tone dominates heart rate
vagal tone
ways that a drug can increase the activity of a synapse
- increase neurotransmitter release into the synapse
- reduce reuptake of the neurotransmitter from the synapse
- reduce degradation of the neurotransmitter in the synapse
- mimic activity of a neurotransmitter at its receptor
ways that a drug can decrease the activity of a synapse
- block a neurotransmitter’s receptor
- inhibit synthesis of a neurotransmitter
- prevent the release of a NT
- prevent packinging in vesicles
general drug mechanisms
- activate M receptors directly
- actiivate M receptors indirecrtly by inhibiting AChE
- Block M receptors
- Inhibit ACh release
drugs that enhance PSNS signaling:
parasympathomimetics, cholinomimetics
drugs that decrease PSNS signaling
parasympatholytics, cholinolytics, anticholinergics
bethanechol
direct-acting muscarininc agonist
bethanechol is resistant to
hydrolysis by AChE and very low nicotinic activity
bethanechol is used for the treatment of
non-obstructive GI hypomotility
irreversible covalent inhibitors
organophosphates
organophosphates form a stable bond that does NOT
hydrolyze spontaneously
pralidoxime (2-PAM)
can remove the drug from AChE if given soon after exposure to organophosphates
clinical use of anticholinesterases
glaucoma
myasthenia gravis